These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 8111066

  • 1. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
    Braaten JV, Jerome WG, Hantgan RR.
    Blood; 1994 Feb 15; 83(4):982-93. PubMed ID: 8111066
    [Abstract] [Full Text] [Related]

  • 2. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
    Braaten JV, Handt S, Jerome WG, Kirkpatrick J, Lewis JC, Hantgan RR.
    Blood; 1993 Mar 01; 81(5):1290-9. PubMed ID: 8443390
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions.
    Huang TC, Jordan RE, Hantgan RR, Alevriadou BR.
    Thromb Res; 2001 Jun 01; 102(5):411-25. PubMed ID: 11395127
    [Abstract] [Full Text] [Related]

  • 4. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC, Dieter JP, Strebel LC, Taylor TM, Muscolino G, Feinberg H, Le Breton GC.
    J Pharmacol Exp Ther; 1991 Dec 01; 259(3):1371-8. PubMed ID: 1762085
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
    Kunitada S, FitzGerald GA, Fitzgerald DJ.
    Blood; 1992 Mar 15; 79(6):1420-7. PubMed ID: 1547340
    [Abstract] [Full Text] [Related]

  • 6. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots.
    Collet JP, Montalescot G, Lesty C, Weisel JW.
    Circ Res; 2002 Mar 08; 90(4):428-34. PubMed ID: 11884372
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR, Sobel BE.
    Thromb Res; 1993 Dec 01; 72(5):413-21. PubMed ID: 8303684
    [Abstract] [Full Text] [Related]

  • 8. Effect of chemical conjugation of recombinant single-chain urokinase-type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivo.
    Dewerchin M, Lijnen HR, Stassen JM, De Cock F, Quertermous T, Ginsberg MH, Plow EF, Collen D.
    Blood; 1991 Aug 15; 78(4):1005-18. PubMed ID: 1831057
    [Abstract] [Full Text] [Related]

  • 9. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.
    Graham DA, Huang TC, Keyt BA, Alevriadou BR.
    Ann Biomed Eng; 1998 Aug 15; 26(4):712-24. PubMed ID: 9662163
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine kinases regulate the cytoskeletal attachment of integrin alpha IIb beta 3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin polymers.
    Schoenwaelder SM, Jackson SP, Yuan Y, Teasdale MS, Salem HH, Mitchell CA.
    J Biol Chem; 1994 Dec 23; 269(51):32479-87. PubMed ID: 7798249
    [Abstract] [Full Text] [Related]

  • 11. The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood.
    Carrieri C, Galasso R, Semeraro F, Ammollo CT, Semeraro N, Colucci M.
    J Thromb Haemost; 2011 Jan 23; 9(1):154-62. PubMed ID: 20961395
    [Abstract] [Full Text] [Related]

  • 12. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus.
    Hantgan RR, Jerome WG, Handt S.
    Thromb Haemost; 1998 Mar 23; 79(3):602-8. PubMed ID: 9531049
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
    Whyte CS, Swieringa F, Mastenbroek TG, Lionikiene AS, Lancé MD, van der Meijden PE, Heemskerk JW, Mutch NJ.
    Blood; 2015 Apr 16; 125(16):2568-78. PubMed ID: 25712989
    [Abstract] [Full Text] [Related]

  • 14. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis.
    Collet JP, Montalescot G, Lesty C, Soria J, Mishal Z, Thomas D, Soria C.
    Arterioscler Thromb Vasc Biol; 2001 Jan 16; 21(1):142-8. PubMed ID: 11145946
    [Abstract] [Full Text] [Related]

  • 15. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R, Gacka M, Kuliszkiewicz-Janus M, Jakobsche-Policht U, Kwiatkowski J, Adamiec R, Undas A.
    Platelets; 2016 Jan 16; 27(2):110-6. PubMed ID: 25989112
    [Abstract] [Full Text] [Related]

  • 16. The significance of fibrin binding by plasminogen activator inhibitor 1 for the mechanism of tissue-type plasminogen activator-mediated fibrinolysis.
    Stringer HA, Pannekoek H.
    J Biol Chem; 1995 May 12; 270(19):11205-8. PubMed ID: 7744752
    [Abstract] [Full Text] [Related]

  • 17. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis.
    Meh DA, Mosesson MW, DiOrio JP, Siebenlist KR, Hernandez I, Amrani DL, Stojanovich L.
    Blood Coagul Fibrinolysis; 2001 Dec 12; 12(8):627-37. PubMed ID: 11734662
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.
    Fay WP, Eitzman DT, Shapiro AD, Madison EL, Ginsburg D.
    Blood; 1994 Jan 15; 83(2):351-6. PubMed ID: 8286735
    [Abstract] [Full Text] [Related]

  • 20. Microfluidic Modeling of Thrombolysis.
    Loyau S, Ho-Tin-Noé B, Bourrienne MC, Boulaftali Y, Jandrot-Perrus M.
    Arterioscler Thromb Vasc Biol; 2018 Nov 15; 38(11):2626-2637. PubMed ID: 30354249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.